Loading organizations...
Loading organizations...
Clinical-stage biotechnology company developing transformative medicines.
Ambros Therapeutics has raised $125.0M across 1 funding round.
Ambros Therapeutics has raised $125.0M in total across 1 funding round.
Ambros Therapeutics has raised $125.0M in total across 1 funding round.
Ambros Therapeutics's investors include Trit Garg, Matthew Hammond, Massimo Di Martino, Adage Capital Management, Arkin Bio Ventures, Balyasny Asset Management, Janus Henderson Investors, Transhuman Capital.
Ambros Therapeutics has raised $125.0M across 1 funding round. Most recently, it raised $125.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2025 | $125.0M Series A | Trit Garg, Matthew Hammond | Massimo Di Martino, Adage Capital Management, Arkin Bio Ventures, Balyasny Asset Management, Janus Henderson Investors, Transhuman Capital |